721 related articles for article (PubMed ID: 31712445)
21. Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
Flemer B; Lynch DB; Brown JM; Jeffery IB; Ryan FJ; Claesson MJ; O'Riordain M; Shanahan F; O'Toole PW
Gut; 2017 Apr; 66(4):633-643. PubMed ID: 26992426
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
23. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
24. Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.
Lin C; Li B; Tu C; Chen X; Guo M
Biomed Res Int; 2022; 2022():3140070. PubMed ID: 35937408
[TBL] [Abstract][Full Text] [Related]
25. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
26. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
27. Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
Goedert JJ; Gong Y; Hua X; Zhong H; He Y; Peng P; Yu G; Wang W; Ravel J; Shi J; Zheng Y
EBioMedicine; 2015 Jun; 2(6):597-603. PubMed ID: 26288821
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota dysbiosis contributes to the development of hypertension.
Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
[TBL] [Abstract][Full Text] [Related]
29. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
30. Dysbiosis signature of fecal microbiota in colorectal cancer patients.
Wu N; Yang X; Zhang R; Li J; Xiao X; Hu Y; Chen Y; Yang F; Lu N; Wang Z; Luan C; Liu Y; Wang B; Xiang C; Wang Y; Zhao F; Gao GF; Wang S; Li L; Zhang H; Zhu B
Microb Ecol; 2013 Aug; 66(2):462-70. PubMed ID: 23733170
[TBL] [Abstract][Full Text] [Related]
31. Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
de Wit S; Geerlings L; Shi C; Dronkers J; Schouten EM; Blancke G; Andries V; Yntema T; Meijers WC; Koonen DPY; Vereecke L; Silljé HHW; Aboumsallem JP; de Boer RA
Cardiovasc Res; 2024 May; 120(6):612-622. PubMed ID: 38400709
[TBL] [Abstract][Full Text] [Related]
32. Gut mycobiome: A promising target for colorectal cancer.
Qin X; Gu Y; Liu T; Wang C; Zhong W; Wang B; Cao H
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188489. PubMed ID: 33278512
[TBL] [Abstract][Full Text] [Related]
33. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
34. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer.
Xia X; Wu WKK; Wong SH; Liu D; Kwong TNY; Nakatsu G; Yan PS; Chuang YM; Chan MW; Coker OO; Chen Z; Yeoh YK; Zhao L; Wang X; Cheng WY; Chan MTV; Chan PKS; Sung JJY; Wang MH; Yu J
Microbiome; 2020 Jul; 8(1):108. PubMed ID: 32678024
[TBL] [Abstract][Full Text] [Related]
35. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers.
Mira-Pascual L; Cabrera-Rubio R; Ocon S; Costales P; Parra A; Suarez A; Moris F; Rodrigo L; Mira A; Collado MC
J Gastroenterol; 2015 Feb; 50(2):167-79. PubMed ID: 24811328
[TBL] [Abstract][Full Text] [Related]
36. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.
Zhang S; Kong C; Yang Y; Cai S; Li X; Cai G; Ma Y
Theranostics; 2020; 10(25):11595-11606. PubMed ID: 33052235
[No Abstract] [Full Text] [Related]
37. Bacteria-related changes in host DNA methylation and the risk for CRC.
Sobhani I; Rotkopf H; Khazaie K
Gut Microbes; 2020 Nov; 12(1):1800898. PubMed ID: 32931352
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
Zhang Q; Zhao H; Wu D; Cao D; Ma W
BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
[TBL] [Abstract][Full Text] [Related]
39. Mucosa-associated microbiota signature in colorectal cancer.
Gao R; Kong C; Huang L; Li H; Qu X; Liu Z; Lan P; Wang J; Qin H
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2073-2083. PubMed ID: 28600626
[TBL] [Abstract][Full Text] [Related]
40. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
